Insider Transactions in Q3 2021 at Karuna Therapeutics, Inc. (KRTX)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 10
2021
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,900
-9.55%
|
$228,000
$120.05 P/Share
|
|
Sep 10
2021
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,900
+8.72%
|
$17,100
$9.2 P/Share
|
|
Sep 09
2021
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
500
-2.7%
|
$60,000
$120.05 P/Share
|
|
Sep 09
2021
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+2.63%
|
$4,500
$9.2 P/Share
|
|
Sep 08
2021
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,600
-15.61%
|
$896,800
$118.59 P/Share
|
|
Sep 08
2021
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,600
+12.5%
|
$68,400
$9.2 P/Share
|
|
Sep 02
2021
|
Andrew Craig Miller President of R&D |
SELL
Open market or private sale
|
Direct |
2,673
-5.69%
|
$334,125
$125.51 P/Share
|
|
Sep 01
2021
|
Andrew Craig Miller President of R&D |
SELL
Open market or private sale
|
Direct |
5,500
-3.59%
|
$649,000
$118.67 P/Share
|
|
Sep 01
2021
|
Atul Pande |
SELL
Open market or private sale
|
Direct |
2,500
-100.0%
|
$292,500
$117.82 P/Share
|
|
Sep 01
2021
|
Atul Pande |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
$40,000
$16.0 P/Share
|
|
Aug 20
2021
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+21.74%
|
$45,000
$9.2 P/Share
|
|
Aug 18
2021
|
Steven M Paul |
BUY
Open market or private purchase
|
Indirect |
1,181
+1.07%
|
$125,186
$106.1 P/Share
|
|
Aug 17
2021
|
Steven M Paul |
BUY
Open market or private purchase
|
Indirect |
1,183
+1.09%
|
$124,215
$105.63 P/Share
|
|
Aug 16
2021
|
Andrew Craig Miller President of R&D |
SELL
Open market or private sale
|
Direct |
5,500
-3.22%
|
$572,000
$104.37 P/Share
|
|
Aug 16
2021
|
Andrew Craig Miller President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+17.73%
|
$25,000
$2.92 P/Share
|
|
Aug 02
2021
|
Atul Pande |
SELL
Open market or private sale
|
Direct |
2,500
-100.0%
|
$285,000
$114.17 P/Share
|
|
Aug 02
2021
|
Atul Pande |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
$40,000
$16.0 P/Share
|
|
Jul 02
2021
|
James Healy |
BUY
Open market or private purchase
|
Indirect |
636
+50.0%
|
$74,412
$117.8 P/Share
|
|
Jul 01
2021
|
Atul Pande |
SELL
Open market or private sale
|
Direct |
2,500
-100.0%
|
$280,000
$112.66 P/Share
|
|
Jul 01
2021
|
Atul Pande |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
$40,000
$16.0 P/Share
|